16mg Betahistine Hydrochloride Tablets IP

Product Description

The 16Mg Betahistine Hydrochloride Tablets IP are a highly successful drug for treating Meniere's syndrome, which can include vertigo, nausea, tinnitus, hearing loss, and nausea. First-line oral therapy involves taking 16 mg three times daily, ideally with meals. These kind of tablets, which are sold under the trade name HISTIMET-8, have minimal adverse effects and exceptional favourable outcomes because they have successfully undergone laboratory testing. The 10x10 tablet blister packaging of the 16Mg Betahistine Hydrochloride Tablets IP is readily available at cost-effective prices.